Efficient inhibition of 4EBP1 phosphorylation has been suggested to be critical for suppression of cancer cell proliferation40, and could explain, at least in part, the superior efficacy of gedatolisib versus single-node PAM inhibitors. The gene discussed is EIF4EBP1; the disease is cancer.